March 2, 2017 – A jury trial between Plaintiff W.L. Gore & Associates Inc. and C.R. Bard Inc. began on March 1 in the District of Delaware, after a complaint filed in June of 2011. Gore alleges infringement of its stent graft patent by Bard, while Bard argues invalidity of the patent. The patent-in-suit is U.S. Patent No. 5,735,892, titled “Intraluminal stent graft.” The trial is in the United States District Court for the District of Delaware, and is number 11-cv-00515.
By: Katherine E. Adams